Craft

Fortress Biotech

Stock Price

$2

2024-10-29

Market Capitalization

$55.7 M

2024-10-29

Revenue

$63.3 M

FY, 2025

Fortress Biotech Summary

Company Summary

Overview
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. The Company develops and commercializes products both within Fortress and through certain of its subsidiary companies, also known as Fortress Companies. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities. 
Type
Public
Status
Active
Founded
2006
HQ
New York, NY, US | view all locations
Website
http://www.fortressbiotech.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Lindsay A. Rosenwald

    Lindsay A. Rosenwald, Chairman, President and Chief Executive Officer

    • Michael S. Weiss

      Michael S. Weiss, Executive Vice Chairman, Strategic Development

      • George Avgerinos

        George Avgerinos, Senior Vice President, Biologics Operations

      • David Jin

        David Jin, Chief Financial Officer and Head of Corporate Development

        LocationsView all

        2 locations detected

        • New York, NY HQ

          United States

          2 Gansevoort St

        • Waltham, MA

          United States

          95 Sawyer Rd #110

        Fortress Biotech Financials

        Summary Financials

        Revenue (Q1, 2026)
        $16.0M
        Gross profit (Q1, 2026)
        $9.8M
        Net income (Q1, 2026)
        $137.2M
        Cash (Q1, 2026)
        $255.8M
        EBIT (Q1, 2026)
        ($7.7M)
        Enterprise value
        ($146.5M)

        Footer menu